Plain-English translation of NCT07118046 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding advanced heart mapping technology (called electroanatomic mapping) improves a newer type of heart ablation procedure for atrial fibrillation. Researchers want to see if this extra mapping tool helps doctors deliver treatment more effectively compared to using standard imaging alone. Both groups will receive the same minimally invasive procedure; one group will have the added mapping guidance during their treatment.
Atrial fibrillation causes an irregular heartbeat that can lead to serious complications. Doctors are always looking for better ways to guide these delicate heart procedures to make them safer and more effective, and this trial is testing whether additional imaging technology can improve the procedure's success.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. Both groups will undergo the same minimally invasive heart ablation procedure performed under sedation. The main difference is that one group will receive standard imaging guidance, while the other group will also have advanced heart mapping technology to guide the procedure. After at least 30 days, you will return for a follow-up heart scan to see how well the procedure worked, regardless of whether you experienced any symptom recurrence.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Spain